Takeda Pharmaceutical Net Profit Margin 2007-2020 | TAK

Current and historical net profit margin for Takeda Pharmaceutical (TAK) from 2007 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue. Takeda Pharmaceutical net profit margin for the three months ending June 30, 2020 was .
Takeda Pharmaceutical Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $30.01B $1.36B 4.54%
2020-03-31 $30.28B $0.41B 1.35%
2019-12-31 $27.62B $0.35B 1.28%
2019-09-30 $23.85B $1.37B 5.74%
2019-06-30 $20.34B $2.17B 10.67%
2018-12-31 $16.65B $3.29B 19.73%
2018-06-30 $15.87B $3.15B 19.86%
2017-06-30 $15.40B $0.54B 3.50%
2016-06-30 $15.52B $-0.61B -3.92%
2015-06-30 $15.56B $-1.27B -8.19%
2015-03-31 $15.92B $-1.15B -7.22%
2014-12-31 $16.23B $0.70B 4.31%
2014-09-30 $16.60B $1.00B 6.02%
2014-06-30 $16.75B $1.10B 6.57%
2014-03-31 $16.90B $1.07B 6.33%
2013-12-31 $16.64B $1.58B 9.46%
2013-09-30 $17.07B $1.35B 7.93%
2013-06-30 $17.79B $1.40B 7.89%
2013-03-31 $18.71B $2.23B 11.90%
2012-12-31 $19.80B $1.30B 6.59%
2012-09-30 $20.33B $1.39B 6.84%
2012-06-30 $19.84B $1.76B 8.85%
2012-03-31 $18.87B $1.03B 5.46%
2011-12-31 $17.78B $1.92B 10.78%
2011-09-30 $12.30B $1.59B 12.96%
2011-03-31 $11.44B $1.52B 13.33%
2010-03-31 $10.16B $0.21B 2.05%
2009-09-30 $8.96B $0.37B 4.07%
2009-03-31 $11.33B $0.64B 5.66%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $58.263B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.484B 43.51
Astellas Pharma (ALPMY) Japan $28.374B 14.38
Eisai (ESALY) Japan $26.558B 22.44
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $19.212B 25.19
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $14.074B 45.75
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Grifols, S.A (GRFS) Spain $10.918B 13.35
Neurocrine Biosciences (NBIX) United States $9.260B 35.85
IPSEN SA ADR (IPSEY) France $9.086B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.708B 12.75
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $7.013B 44.42
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $4.486B 10.37
Arrowhead Pharmaceuticals (ARWR) United States $4.267B 0.00
Evotec AG (EVTCY) Germany $4.014B 139.34
FibroGen (FGEN) United States $3.930B 0.00
ChemoCentryx (CCXI) United States $3.598B 0.00
Hypermarcas (HYPMY) Brazil $3.508B 12.90
Nektar Therapeutics (NKTR) United States $3.472B 0.00
Sage Therapeutics (SAGE) United States $3.112B 0.00
PTC Therapeutics (PTCT) United States $3.078B 0.00
Pacira BioSciences (PCRX) United States $2.555B 67.16
Xencor (XNCR) United States $2.199B 0.00
Revolution Medicines (RVMD) United States $2.180B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.126B 10.29
Corcept Therapeutics (CORT) United States $2.079B 19.14
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.881B 0.00
Cronos Group (CRON) Canada $1.791B 0.00
USANA Health Sciences (USNA) United States $1.591B 14.99
Ironwood Pharmaceuticals (IRWD) United States $1.552B 10.78
Indivior (INVVY) United States $1.504B 18.64
Heron Therapeutics (HRTX) United States $1.377B 0.00
Trillium Therapeutics (TRIL) Canada $1.314B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.271B 12.11
Zogenix (ZGNX) United States $1.265B 0.00
Karyopharm Therapeutics (KPTI) United States $1.182B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.088B 0.00
Esperion Therapeutics (ESPR) United States $1.040B 0.00
Translate Bio (TBIO) United States $1.021B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
VAXART, INC (VXRT) United States $0.982B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.899B 559.88
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Endo (ENDP) Ireland $0.722B 1.07
Spectrum Pharmaceuticals (SPPI) United States $0.694B 0.00
ImmunoGen (IMGN) United States $0.665B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.664B 0.00
Collegium Pharmaceutical (COLL) United States $0.643B 0.00
Tilray (TLRY) Canada $0.636B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.587B 0.00
Ocular Therapeutix (OCUL) United States $0.563B 0.00
Siga Technologies (SIGA) United States $0.561B 59.88
Flexion Therapeutics (FLXN) United States $0.546B 0.00
Radius Health (RDUS) United States $0.542B 0.00
Aerie Pharmaceuticals (AERI) United States $0.538B 0.00
Molecular Templates (MTEM) United States $0.537B 0.00
Ardelyx (ARDX) United States $0.511B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.503B 0.00
Altimmune (ALT) United States $0.447B 0.00
Harpoon Therapeutics (HARP) United States $0.438B 0.00
Organogenesis Holdings (ORGO) United States $0.406B 0.00
Akebia Therapeutics (AKBA) United States $0.404B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.404B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.393B 19.60
TherapeuticsMD (TXMD) United States $0.381B 0.00
MEI Pharma (MEIP) United States $0.367B 0.00
Redhill Biopharma (RDHL) Israel $0.360B 0.00
DURECT (DRRX) United States $0.351B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.332B 8.23
PROFOUND MEDICL (PROF) Canada $0.332B 0.00
Innate Pharma SA (IPHYF) France $0.324B 0.00
IMV INC (IMV) Canada $0.315B 0.00
Xeris Pharmaceuticals (XERS) United States $0.305B 0.00
Concert Pharmaceuticals (CNCE) United States $0.304B 0.00
Jounce Therapeutics (JNCE) United States $0.304B 14.39
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Menlo Therapeutics (VYNE) United States $0.287B 0.00
Rafael Holdings (RFL) United States $0.278B 0.00
Calithera Biosciences (CALA) United States $0.254B 0.00
Lannett Co Inc (LCI) United States $0.247B 5.75
KalVista Pharmaceuticals (KALV) United States $0.238B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.228B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.226B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 21.04
Heat Biologics (HTBX) United States $0.207B 0.00
CASI Pharmaceuticals (CASI) United States $0.198B 0.00
OptiNose (OPTN) United States $0.189B 0.00
Nivalis Therapeutics (ALPN) United States $0.186B 0.00
Otonomy (OTIC) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.163B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.157B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.141B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 0.00
Aclaris Therapeutics (ACRS) United States $0.106B 0.00
Lipocine (LPCN) United States $0.105B 0.00
MediWound (MDWD) Israel $0.099B 0.00
Biomerica (BMRA) United States $0.085B 0.00
CTI BioPharma (CTIC) United States $0.083B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
Novan (NOVN) United States $0.074B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.070B 0.00
Addex Therapeutics (ADXN) Switzerland $0.070B 0.00
Onconova Therapeutics (ONTX) United States $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.065B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.058B 0.00
Recro Pharma (REPH) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.00
CV Sciences (CVSI) United States $0.052B 0.00
KemPharm (KMPH) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.36
India Globalization Capital (IGC) United States $0.047B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
GTx (ONCT) United States $0.042B 0.00
ProPhase Labs (PRPH) United States $0.042B 0.00
IsoRay (ISR) United States $0.041B 0.00
PolarityTE (PTE) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.96
AgeX Therapeutics (AGE) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
Sundial Growers (SNDL) Canada $0.025B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.016B 24.45
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00